Editas Share Price

Editas Share Price

NASDAQ: EDIT | Micro Cap | Healthcare
$1.71
-$0.05 (-3.12%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Editas Stock Performance

Open
$1.75
Prev. Close
$1.76
Circuit Range
N/A
Day Range
$1.71 - $1.83
Year Range
$1.66 - $3.94
Volume
1,19,929
Average Traded
$1.77

Editas Share Price Today

As of 20 November 2026, Editas Medicine, Inc.'s share price is $1.71. The stock opened at $1.75, compared to its previous close of $1.76. During today's trading session, Editas Medicine, Inc.'s share price traded between $1.71 and $1.83, with an average price of $1.77. Over the past 52 weeks, the stock has recorded a high of $3.94 and a low of $1.66. In terms of performance, Editas Medicine, Inc.'s share price has declined by 50.51% over the last six months and is down 28.75% on a year-on-year basis.

Editas Share Price Chart

Line chart of the Editas price trend over the selected period. The price fell overall, ranging from 1.76 to 1.94, ending at 1.78.
$1.71$1.83
L
Show Current Price
H

Editas Stock Fundamentals & Key Indicators

Market Cap
$151.76M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.47
Revenue (TTM)
$40.52B
Return On Equity (TTM)
-85.45%
Profit Margin
-395.01%
Debt to Equity
0.67
Quarterly Earnings Growth YoY
-316.19%

Editas Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$24.74$2.83$11.89$10.37
Net Profit-$5.62-$24.98-$18.23-$23.39
Net Profit Margin-22.72%-882.69%-153.32%-225.55%
Income ChangeN/A-344.48%27.02%-28.30%

Editas Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$19.71$78.12$32.31$40.52
Net Profit-$220.43-$153.22-$237.09-$160.06
Net Profit Margin-1118.37%-196.13%-733.80%-395.01%
Income ChangeN/A30.49%-54.74%32.49%

Editas Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets22.6452.27158.32157.57
Current Assets163.9289.32340.83356.75
Total Assets186.53341.59499.15514.32
Non Current Liabilities113.0130.0986.8493.53
Current Liabilities46.2577.2363.2260.11
Total Liabilities159.25207.32150.06153.64
Shareholders' Equity27.29134.27349.1360.68

Editas Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-165.24-210.28-132.18-177.35
Investing138.67162.15-3.73114.07
Financing40.4756.03118.041.28

About Editas

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Editas Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.71
$1.71
-36.02%
Oct 2026
$2.61
$2.67
+3.50%
Sep 2026
$3.02
$2.58
-21.97%
Aug 2026
$2.58
$3.30
+28.40%
Jul 2026
$3.33
$2.57
-20.56%
Jun 2026
$3.33
$3.23
-6.37%
May 2026
$2.98
$3.46
+15.17%
Apr 2026
$2.61
$3.00
+21.21%
Mar 2026
$2.10
$2.48
+12.24%
Feb 2026
$1.98
$2.21
+11.36%
Jan 2026
$2.07
$1.98
-3.65%
Dec 2025
$2.36
$2.06
-14.37%

Editas Share Price FAQs